Skip to main content

Table 3 Mean live Amblyomma americanum counts and efficacy relative to placebo at 24 h after treatment and post-treatment re-infestations for dogs treated with a single oral dose of sarolaner or afoxolaner on Day 01

From: Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard®) against induced infestations of Amblyomma americanum on dogs

Treatment

 

Day of treatment or re-infestation

 

0

7

14

21

28

35

Placebo

Range

4–22

14–31

7–33

9–36

17–36

9–26

A. mean

14.1

21.1

22.3

22.0

28.4

20.3

G. mean2

12.6a

20.2a

20.1a

19.9a

27.4a

19.1a

Sarolaner

Range

0–0

0–0

0–2

0–2

0–9

1–20

A. mean

0.0

0.0

0.5

0.4

3.6

8.0

Efficacy (%)

100

100

97.8

98.3

87.2

60.5

G. mean2

0.0b

0.0c

0.4c

0.3c

2.5c

5.5b

Efficacy (%)

100

100

98.2

98.7

91.1

70.9

P-value vs.placebo

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

Afoxolaner

Range

0–0

0–4

0–11

3–16

9–29

10–23

A. mean

0.0

1.5

4.5

9.8

17.7

18.0

Efficacy (%)

100

92.9

79.8

55.3

37.7

11.1

G. mean2

0.0b

0.9b

3.0b

8.5b

16.1b

17.0a

Efficacy (%)

100

95.3

84.9

57.6

41.5

10.6

P-value vs. placebo

<0.0001

<0.0001

<0.0001

0.0025

0.0487

0.6801

P-value vs. sarolaner

0.9525

0.0247

0.0003

<0.0001

<0.0001

0.0007

  1. 1 n = 6 for afoxolaner, n = 8 for placebo and sarolaner groups
  2. 2Geometric means within columns with the same superscript are not significantly different (P > 0.05)